• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Streamex Corp. to Participate in the Clear Street Disruptive Technology Conference on November 19-20, 2025

    9/29/25 8:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $STEX alert in real time by email

    LOS ANGELES, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ: STEX), a leader in institutional-grade tokenization of real-world assets, today announced the executive management team, will participate in one-to-one meetings at the Clear Street Disruptive Technology Conference at The Four Seasons Resort in Palm Beach, Florida, taking place November 19-20, 2025.

    "This conference represents an ideal platform to connect with institutional investors who understand that the transformative potential of real-world asset tokenization is a key innovation," said Henry McPhie, CEO and Co-Founder of Streamex Corp.

    About Streamex Corp.

    Streamex is a real-world asset tokenization company with institutional-grade infrastructure to bring the gold and commodities market on chain. Enabled by a gold-denominated treasury and tokenization technology powering the modern commodities market, Streamex is building a platform to deliver regulated, yield-bearing, and liquid financial products.

    Contacts

    Investor Relations:

    Adele Carey

    VP, Investor Relations

    [email protected]

    Public Relations:

    Fatema Bhabrawala

    Director of Media Relations

    [email protected]

    Streamex:

    Henry McPhie

    Chief Executive Officer, Streamex Corp.

    [email protected]

    www.streamex.com

    https://x.com/streamex



    Primary Logo

    Get the next $STEX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $STEX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $STEX
    SEC Filings

    View All

    SEC Form S-8 filed by Streamex Corp.

    S-8 - Streamex Corp. (0001530766) (Filer)

    10/3/25 5:25:11 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Streamex Corp. (NASDAQ: STEX) to Participate in the 28th Annual Needham Growth Conference

    LOS ANGELES, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a vertically integrated commodity tokenization company, today announced that members of its executive management team will participate in the 28th Annual Needham Growth Conference, to be held January 13–14, 2026, in New York City. The Company's executive leadership will host one-on-one meetings with institutional investors and present information on its yield-bearing gold backed stablecoin, GLDY, as well as other advancements and initiatives. About Streamex Corp. Streamex Corp. is a vertically integrated commodity tokenization company focused on bringing real-world assets, particul

    10/8/25 8:00:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. (NASDAQ: STEX) Announces Pre-Sale of Up to $100,000,000 USD for GLDY, a Gold Backed Stablecoin Asset Offering Up to 4.0% Yield

    Key Highlights Institutional Scale & Balance-Sheet Alignment: $100,000,000 USD in initial pre-sale capacity with near-term expandable issuance of up to $1.0 billion; Streamex to co-invest with a minimum $5,000,000 USD commitment, demonstrating management alignment and balance-sheet support.Institutional Grade Gold Product with Yield: GLDY is a physical bullion backed stablecoin that delivers up to 4.0% annualized yield (paid in ounces of physical gold) through gold-leasing, combining capital preservation of physical gold with predictable income.Regulated, Institutional Infrastructure: To be launched through the Streamex platform and distributed through institutional channels, GLDY is engine

    10/6/25 8:00:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. to Participate in the Clear Street Disruptive Technology Conference on November 19-20, 2025

    LOS ANGELES, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ: STEX), a leader in institutional-grade tokenization of real-world assets, today announced the executive management team, will participate in one-to-one meetings at the Clear Street Disruptive Technology Conference at The Four Seasons Resort in Palm Beach, Florida, taking place November 19-20, 2025. "This conference represents an ideal platform to connect with institutional investors who understand that the transformative potential of real-world asset tokenization is a key innovation," said Henry McPhie, CEO and Co-Founder of Streamex Corp. About Streamex Corp.Streamex is a real-world ass

    9/29/25 8:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care